1014PDPhase I/II, first in human trial with M7583, a...

1014PDPhase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies

Jurczak, W, Rule, S, Townsend, W, Tucker, D, Sarholz, B, Scheele, J, Gribben, J, Zinzani, P L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy286.010
Date:
October, 2018
File:
PDF, 94 KB
2018
Conversion to is in progress
Conversion to is failed